Preclinical Imaging Market, By Product Type (Imaging Systems, Reagents & Probes/Contrast Agents, and Software & Services), By Modality, By Application, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4769
|
Published Date
February 2026
|
Pages
348
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Preclinical Imaging Market size was valued at US$ 995.98 Million in 2024, expanding at a CAGR of 5.54% from 2025 to 2032.
The preclinical imaging market encompasses equipment, imaging agents, and software used to study diseases and assess drug effects in live animal models before human clinical trials. These tools are critical in early-stage research, enabling repeated, non-invasive monitoring of tumors, organs, and biological processes over time, which helps accelerate decision-making in drug discovery. Common imaging modalities include micro-CT and micro-MRI for detailed anatomical studies, PET and SPECT for functional or molecular imaging, and optical imaging for rapid screening using fluorescent or bioluminescent probes. Many laboratories combine multiple modalities to enhance study precision and reliability.
Market demand is driven by research in areas such as oncology, neurology, and infectious diseases, as well as the increasing development of biologics and advanced therapies that require robust in vivo evidence of mechanism of action and biodistribution. Government research spending reflects this trend: according to the U.S. National Institutes of Health (NIH) Research & Development Funding Trends, the U.S. federal investment in biomedical research reached approximately $49 billion in 2023, with substantial allocations toward preclinical and translational studies. Similarly, the European Commission’s Horizon Europe program allocated over €13 billion in 2021–2022 for health and biotechnology research, supporting the use of advanced imaging technologies in preclinical models. These public investments underline the strategic importance of preclinical imaging in drug development globally. For buyers—including pharmaceutical companies, contract research organizations (CROs), and academic research institutes—key considerations typically include image quality, sensitivity, workflow efficiency, software for quantification and reporting, compatibility with probes and tracers, service and maintenance support, and total cost of ownership. High-quality preclinical imaging is particularly valuable because it can reduce early-stage uncertainty, helping researchers identify promising candidates sooner and avoid costly failures later in the drug development pipeline.
Preclinical Imaging Market- Market Dynamics
Growing Government-Funded Biomedical Research and Expanding Clinical Pipelines Boost Demand for Preclinical Imaging
Demand for preclinical imaging is increasing as rising biomedical research funding and a growing flow of drug development programs require robust in vivo data before costly clinical trials, particularly in oncology, neuroscience, and advanced therapies, where monitoring biodistribution and treatment response is critical. According to the U.S. National Science Foundation (NSF), total U.S. research and development spending reached approximately USD 892 billion in 2022, reflecting the scale of R&D activity that supports laboratories, contract research organizations (CROs), and equipment investment. In the health-focused sector, the National Institutes of Health (NIH) reported budget authority of about USD 47.5 billion for FY2023 and USD 48.0 billion for FY2024, underpinning numerous preclinical studies that rely on small-animal imaging for longitudinal measurements. The extensive clinical development pipeline further underscores ongoing preclinical demand: ClinicalTrials.gov (U.S. National Library of Medicine) listed over 500,000 active studies in 2024–2025, many of which require imaging-based proof-of-concept, target engagement, and safety assessments before advancing to human trials. These public statistics highlight a key market driver: consistent funding and a robust pipeline create sustained need for imaging systems, contrast agents, and analysis software capable of delivering repeatable results, faster study timelines, and more confident go/no-go decisions.
Preclinical Imaging Market- Segmentation Analysis:
Demand for preclinical imaging is closely linked to the activity level of the drug development pipeline and the availability of public research funding, since higher R&D activity drives more animal studies requiring precise in vivo measurements. One way to gauge pipeline scale is through clinical trial registrations: according to ClinicalTrials.gov (U.S. National Library of Medicine), more than 500,000 studies were listed during 2024–2025, signaling robust global development work that typically relies on comprehensive preclinical data before advancing programs. Funding reinforces this trend at the research level; the National Institutes of Health (NIH) reported budget authority of approximately USD 47.5 billion in FY2023 and around USD 48.0 billion in FY2024, supporting active research in oncology, neurology, and infectious diseases, where small-animal imaging is often used for longitudinal monitoring and treatment response assessment. In Europe, overall R&D intensity remains strong: according to Eurostat, EU gross domestic expenditure on R&D stayed above 2% of GDP in 2022–2023, sustaining demand for imaging equipment in universities and research institutes.
Technology requirements within studies also influence purchasing decisions. Programs that require both structural detail and functional or molecular readouts drive adoption of combined imaging workflows and advanced analysis software. Tracer-based imaging, such as PET and SPECT, depends on nuclear medicine infrastructure and isotope availability. According to the International Atomic Energy Agency (IAEA), nuclear medicine capacity expanded across member states in the early 2020s, supporting the ecosystem necessary for preclinical molecular imaging. At the same time, growing expectations for consistency, reproducibility, and documentation are increasing demand for systems capable of delivering repeatable scans, high uptime, and standardized reporting—especially in CRO-style environments where throughput and cross-study comparability are critical.
Preclinical Imaging Market- Geographical Insights
Preclinical imaging demand is typically strongest in regions with high biomedical R&D spending, extensive university and hospital research networks, and active drug development pipelines, all of which drive steady requirements for imaging systems, probes, and analysis software. North America remains a key market due to its large and stable public research budgets; the National Institutes of Health (NIH) reported budget authority of approximately USD 47.5 billion in FY2023 and around USD 48.0 billion in FY2024, supporting numerous imaging-intensive programs in oncology, neuroscience, and infectious disease. Europe also demonstrates sustained research activity, with Eurostat reporting that EU gross domestic expenditure on R&D remained above 2% of GDP in 2022–2023, enabling ongoing equipment purchases and facility upgrades at academic and government research institutes. The size of the clinical development pipeline further highlights preclinical demand: according to ClinicalTrials.gov (U.S. National Library of Medicine), more than 500,000 studies were registered during 2024–2025, reflecting a substantial global development funnel that relies on preclinical imaging for proof-of-concept, translational biomarker studies, and safety assessments.
United States Preclinical Imaging Market- Country Insights
The United States represents the strongest single-country market for preclinical imaging due to its large biomedical research funding base, a high concentration of active research organizations, and a close link between translational studies and pharma, biotech, and CRO activity. Public funding is a primary driver: according to the National Institutes of Health (NIH), annual budget authority remained near USD 48 billion in FY2024, sustaining steady demand for small-animal imaging systems and related consumables. The broader research ecosystem is also substantial; the U.S. National Science Foundation (NSF) reported total R&D spending of approximately USD 892 billion in 2022, reflecting significant capacity for advanced instruments and specialized workflows. Drug development activity further reinforces demand: ClinicalTrials.gov (U.S. National Library of Medicine) listed over 500,000 registered studies during 2024–2025, indicating a continuous need for imaging-based proof-of-concept, biodistribution analysis, and response monitoring before clinical progression.
Preclinical Imaging Market- Competitive Landscape:
The preclinical imaging vendor landscape is typically defined by modality expertise and workflow integration, as buyers evaluate systems based on resolution, sensitivity, throughput, software quantification, and post-sale support. Bruker Corporation is widely recognized for preclinical MRI and micro-CT platforms and integrated imaging workflows for research laboratories. Revvity, Inc. is often associated with optical imaging and reagent ecosystems for rapid in vivo screening and longitudinal studies. FUJIFILM VisualSonics Inc. is noted for high-resolution preclinical ultrasound and photoacoustic imaging, particularly in cardiovascular and oncology research. In nuclear imaging, MILabs B.V. and Mediso Ltd. are frequently cited for PET/SPECT systems and multi-modal configurations supporting tracer-based studies. Larger imaging groups—including Siemens Healthineers AG, GE HealthCare Technologies Inc., Koninklijke Philips N.V., and Canon Medical Systems Corporation—also play a role, offering imaging technologies and software that facilitate translational research collaborations. Competition is reinforced by public funding and pipeline scale; according to NIH and ClinicalTrials.gov (U.S. National Library of Medicine), substantial research budgets and the large number of registered studies continue to drive investment in higher-throughput systems, multi-modality setups, and standardized analysis tools.
Recent Developments:
- October 2025: The START Center for Cancer Research, together with its preclinical division XenoSTART and radiopharmaceutical CRO/CDMO Minerva Imaging, expanded their collaboration to create an integrated platform for radiopharmaceutical drug development. The initiative combines clinically annotated patient-derived xenograft (PDX) models with advanced imaging modalities—including PET/CT, SPECT/CT, and MRI—alongside GMP manufacturing, aiming to shorten development timelines and reduce risk in oncology radiopharmaceutical programs.
- September 2025: Revvity, Inc. launched Living Image™ Synergy AI, a multimodal in vivo imaging analysis software platform that integrates data from optical, micro-CT, ultrasound, and other modalities. The software incorporates AI-based automation for image segmentation and ROI quantification, improving throughput, reproducibility, and reducing manual processing. It was showcased at the World Molecular Imaging Congress (WMIC) in late September 2025.
- September 2023: Revvity, Inc. expanded its preclinical imaging portfolio with the next-generation IVIS® Spectrum 2 and IVIS SpectrumCT 2 optical systems, the Quantum™ GX3 micro-CT solution, and the global debut of the Vega® ultrasound system. These platforms aim to deliver higher sensitivity, improved resolution, and faster throughput for in vivo and ex vivo research workflows, and were presented at the WMIC in Prague.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL PRECLINICAL IMAGING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Aspect Imaging Ltd.
- BIONANO GENOMICS, INC.
- Biospace Lab S.A.
- Bruker Corporation
- Canon Medical Systems Corporation
- CubiX Imaging, Inc.
- FUJIFILM VisualSonics Inc.
- GE HealthCare Technologies Inc.
- Mediso Ltd.
- MILabs B.V.
- MinFound Medical Systems Co., Ltd.
- MR Solutions Group Ltd.
- Nanoscan Imaging Ltd.
- PerkinElmer Inc.
- Philips International B.V.
- Revvity, Inc.
- Siemens Healthineers AG
- Sofie Biosciences, Inc.
- TriFoil Imaging, Inc.
- Trifoil Imaging, Inc.
- Others
GLOBAL PRECLINICAL IMAGING MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032
- Imaging Systems
- Reagents & Probes/Contrast Agents
- Software & Services
GLOBAL PRECLINICAL IMAGING MARKET, BY MODALITY- MARKET ANALYSIS, 2019 - 2032
- Optical Imaging
- MRI
- CT
- PET
- SPECT
- Ultrasound
- Photoacoustic Imaging
GLOBAL PRECLINICAL IMAGING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Oncology
- Neurology
- Cardiology
- Infectious Diseases
- Others
GLOBAL PRECLINICAL IMAGING MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations (CROs)
- Academic & Research Institutes
- Others
GLOBAL PRECLINICAL IMAGING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Preclinical Imaging Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Preclinical Imaging Market Snippet by Product Type
2.1.2. Preclinical Imaging Market Snippet by Modality
2.1.3. Preclinical Imaging Market Snippet by Application
2.1.4. Preclinical Imaging Market Snippet by End User
2.1.5. Preclinical Imaging Market Snippet by Country
2.1.6. Preclinical Imaging Market Snippet by Region
2.2. Competitive Insights
3. Preclinical Imaging Key Market Trends
3.1. Preclinical Imaging Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Preclinical Imaging Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Preclinical Imaging Market Opportunities
3.4. Preclinical Imaging Market Future Trends
4. Preclinical Imaging Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Preclinical Imaging Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Preclinical Imaging Market Landscape
6.1. Preclinical Imaging Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Preclinical Imaging Market – By Product Type
7.1. Overview
7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
7.1.2. Imaging Systems
7.1.3. Reagents & Probes/Contrast Agents
7.1.4. Software & Services
8. Preclinical Imaging Market – By Modality
8.1. Overview
8.1.1. Segment Share Analysis, By Modality, 2024 & 2032 (%)
8.1.2. Optical Imaging
8.1.3. MRI
8.1.4. CT
8.1.5. PET
8.1.6. SPECT
8.1.7. Ultrasound
8.1.8. Photoacoustic Imaging
9. Preclinical Imaging Market – By Application
9.1. Overview
9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
9.1.2. Oncology
9.1.3. Neurology
9.1.4. Cardiology
9.1.5. Infectious Diseases
9.1.6. Others
10. Preclinical Imaging Market – By End User
10.1. Overview
10.1.1. Segment Share Analysis, By Modality, 2024 & 2032 (%)
10.1.2. Pharmaceutical & Biotechnology Companies
10.1.3. Contract Research Organizations (CROs)
10.1.4. Academic & Research Institutes
10.1.5. Others
11. Preclinical Imaging Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
11.2. North America
11.2.1. Overview
11.2.2. Preclinical Imaging Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.2.5. North America Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Preclinical Imaging Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.10.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.17. Rest of Europe
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.17.4. Rest of the Europe Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.17.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Preclinical Imaging Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.7. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.8.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.9.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. Preclinical Imaging Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. Preclinical Imaging Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.7. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12. Key Vendor Analysis- Preclinical Imaging Industry
12.1. Competitive Benchmarking
12.1.1. Competitive Dashboard
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. Aspect Imaging Ltd.
12.2.2. BIONANO GENOMICS, INC.
12.2.3. Biospace Lab S.A.
12.2.4. Bruker Corporation
12.2.5. Canon Medical Systems Corporation
12.2.6. CubiX Imaging, Inc.
12.2.7. FUJIFILM VisualSonics Inc.
12.2.8. GE HealthCare Technologies Inc.
12.2.9. Mediso Ltd.
12.2.10. MILabs B.V.
12.2.11. MinFound Medical Systems Co., Ltd.
12.2.12. MR Solutions Group Ltd.
12.2.13. Nanoscan Imaging Ltd.
12.2.14. PerkinElmer Inc.
12.2.15. Philips International B.V.
12.2.16. Revvity, Inc.
12.2.17. Siemens Healthineers AG
12.2.18. Sofie Biosciences, Inc.
12.2.19. TriFoil Imaging, Inc.
12.2.20. Trifoil Imaging, Inc.
12.2.21. Others
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL PRECLINICAL IMAGING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Aspect Imaging Ltd.
- BIONANO GENOMICS, INC.
- Biospace Lab S.A.
- Bruker Corporation
- Canon Medical Systems Corporation
- CubiX Imaging, Inc.
- FUJIFILM VisualSonics Inc.
- GE HealthCare Technologies Inc.
- Mediso Ltd.
- MILabs B.V.
- MinFound Medical Systems Co., Ltd.
- MR Solutions Group Ltd.
- Nanoscan Imaging Ltd.
- PerkinElmer Inc.
- Philips International B.V.
- Revvity, Inc.
- Siemens Healthineers AG
- Sofie Biosciences, Inc.
- TriFoil Imaging, Inc.
- Trifoil Imaging, Inc.
- Others
GLOBAL PRECLINICAL IMAGING MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032
- Imaging Systems
- Reagents & Probes/Contrast Agents
- Software & Services
GLOBAL PRECLINICAL IMAGING MARKET, BY MODALITY- MARKET ANALYSIS, 2019 - 2032
- Optical Imaging
- MRI
- CT
- PET
- SPECT
- Ultrasound
- Photoacoustic Imaging
GLOBAL PRECLINICAL IMAGING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Oncology
- Neurology
- Cardiology
- Infectious Diseases
- Others
GLOBAL PRECLINICAL IMAGING MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations (CROs)
- Academic & Research Institutes
- Others
GLOBAL PRECLINICAL IMAGING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
